Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft-versus-host Disease Prevention”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03689465
What this trial is testing

PTCy-ATG vs ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 260
Testing effectiveness (Phase 2)Study completedNCT02867384
What this trial is testing

Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
Graft vs. Host Disease
Dana-Farber Cancer Institute 181
Testing effectiveness (Phase 2)Active Not RecruitingNCT05621759
What this trial is testing

Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

Who this might be right for
Graft Vs Host Disease
NYU Langone Health 27
Post-approval studies (Phase 4)UnknownNCT04203108
What this trial is testing

ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 266
Testing effectiveness (Phase 2)Ended earlyNCT01220297
What this trial is testing

Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

Who this might be right for
Hematologic DiseasesAcute-graft-versus-host DiseaseLeukemia+2 more
Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT00803010
What this trial is testing

Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Acute Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 74
Testing effectiveness (Phase 2)Study completedNCT02876679
What this trial is testing

Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT

Who this might be right for
Graft vs Host Disease
Assistance Publique - Hôpitaux de Paris 94
Testing effectiveness (Phase 2)Looking for participantsNCT06859424
What this trial is testing

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
AML (Acute Myelogenous Leukemia)Acute Lymphoid Leukemia (ALL)Acute Leukemia (Category)+8 more
Center for International Blood and Marrow Transplant Research 358
Testing effectiveness (Phase 2)Looking for participantsNCT07006506
What this trial is testing

Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseGraft Vs Host DiseaseHematologic Malignancy
Memorial Sloan Kettering Cancer Center 46
Large-scale testing (Phase 3)Study completedNCT01231412
What this trial is testing

Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+16 more
Fred Hutchinson Cancer Center 174
Testing effectiveness (Phase 2)Ended earlyNCT00005641
What this trial is testing

Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
H. Lee Moffitt Cancer Center and Research Institute
Not applicableNot Yet RecruitingNCT07702383
What this trial is testing

A Multicentre Randomised Controlled Trial Evaluating the Efficacy of the SMILE™ Module for Improving Short-term Periodontal Outcomes, Compliance, and Acceptability Among Clinical Dental Students

Who this might be right for
GingivitisGingivitis; Chronic
National University of Malaysia 66
Post-approval studies (Phase 4)Study completedNCT02342145
What this trial is testing

Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

Who this might be right for
Beta-Thalassemia MajorGraft-versus-host Disease (GVHD)
Zhongming Zhang 205
Testing effectiveness (Phase 2)Study completedNCT00141739
What this trial is testing

Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Graft-Versus-Host Disease
University of Michigan Rogel Cancer Center 100
Not applicableNot Yet RecruitingNCT07440654
What this trial is testing

Efficacy and Safety of Gecacitinib Hydrochloride in Prophylaxis Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelofibrosis

Who this might be right for
aGVHD Prophylaxis
Nanfang Hospital, Southern Medical University 40
Early research (Phase 1)Ended earlyNCT02231710
What this trial is testing

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

Who this might be right for
Primary Immune Deficiency DisordersHemophagocytic LymphohistiocytosisInherited Bone Marrow Failure Syndrome+2 more
Bellicum Pharmaceuticals 1
Early research (Phase 1)Study completedNCT03207958
What this trial is testing

Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-disease
Washington University School of Medicine 10
Early research (Phase 1)Looking for participantsNCT06462365
What this trial is testing

Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)

Who this might be right for
Hematologic MalignancyGvHDGVHD,Acute+8 more
Tr1X, Inc. 36
Testing effectiveness (Phase 2)Looking for participantsNCT05289167
What this trial is testing

Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)

Who this might be right for
Graft-versus-host Disease
Northwell Health 74
Testing effectiveness (Phase 2)Study completedNCT02065154
What this trial is testing

Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome+3 more
University of Alabama at Birmingham 39
Next Page